3D Printing as a Strategy to Scale-Up Biohybrid Hydrogels for T Cell Manufacture.

ABSTRACT: The emergence of cellular immunotherapy treatments is introducing more efficient strategies to combat cancer as well as autoimmune and infectious diseases. However, the cellular manufacturing procedures associated with these therapies remain costly and time-consuming, thus limiting their applicability. Recently, lymph-node-inspired PEG-heparin hydrogels have been demonstrated to improve primary human T cell culture at the laboratory scale. To go one step further in their clinical applicability, we assessed their scalability, which was successfully achieved by 3D printing. Thus, we were able to improve primary human T cell infiltration in the biohybrid PEG-heparin hydrogels, as well as increase nutrient, waste, and gas transport, resulting in higher primary human T cell proliferation rates

SUBMITTER: Perez Del Rio E 

PROVIDER: S-EPMC11440455 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature